Figure 1
Figure 1. High-level fetal liver chimerism in embryos generated from W41/W41 blastocyst complementations. (A) GFP-expressing ES cells were injected into wild-type or W41/W41 blastocysts, and fetal livers were isolated from E14.5 embryos. The percentage of GFP+ cells in each liver was measured by FACS analysis within the Lin− subpopulation. Distribution of GFP chimerism in the fetal liver of embryos from W41/W41 or wild-type blastocysts. (B) GFP+ ES cells were injected into W41/W41 or wild-type blastocysts. E14.5 embryos were harvested, and 2 million chimeric fetal liver cells (CD45.2) were transplanted into CD45.1 recipient mice. FACS profiles for 5 mice transplanted with pooled cells from 4 randomly picked W41/W41 chimeric embryos. A control mouse transplanted with cells from a high-level wild-type chimera is shown as reference. Percentage of GFP+ donor cells in peripheral blood (PB) and bone marrow (BM) after 8 and 18 weeks, respectively.

High-level fetal liver chimerism in embryos generated from W41/W41 blastocyst complementations. (A) GFP-expressing ES cells were injected into wild-type or W41/W41 blastocysts, and fetal livers were isolated from E14.5 embryos. The percentage of GFP+ cells in each liver was measured by FACS analysis within the Lin subpopulation. Distribution of GFP chimerism in the fetal liver of embryos from W41/W41 or wild-type blastocysts. (B) GFP+ ES cells were injected into W41/W41 or wild-type blastocysts. E14.5 embryos were harvested, and 2 million chimeric fetal liver cells (CD45.2) were transplanted into CD45.1 recipient mice. FACS profiles for 5 mice transplanted with pooled cells from 4 randomly picked W41/W41 chimeric embryos. A control mouse transplanted with cells from a high-level wild-type chimera is shown as reference. Percentage of GFP+ donor cells in peripheral blood (PB) and bone marrow (BM) after 8 and 18 weeks, respectively.

Close Modal

or Create an Account

Close Modal
Close Modal